 | Up a level |
Dangas, George D; Tijssen, Jan G P; Wöhrle, Jochen; Søndergaard, Lars; Gilard, Martine; Möllmann, Helge; Makkar, Raj R; Herrmann, Howard C; Giustino, Gennaro; Baldus, Stephan; De Backer, Ole; Guimarães, Ana H C; Gullestad, Lars; Kini, Annapoorna; von Lewinski, Dirk; Mack, Michael; Moreno, Raúl; Schäfer, Ulrich; Seeger, Julia; Tchétché, Didier; ... (2020). A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 382(2), pp. 120-129. Massachusetts Medical Society 10.1056/NEJMoa1911425
Gustafsson, Finn; Gude, Einar; Sigurdardottir, Vilborg; Aukrust, Pål; Solbu, Dag; Goetze, Jens-Peter; Gullestad, Lars (2014). Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels. Biomarkers in medicine, 8(2), pp. 239-245. Future Medicine 10.2217/bmm.13.95
Arora, Satish; Gude, Einar; Sigurdardottir, Vilborg; Mortensen, Svend Aage; Eiskjær, Hans; Riise, Gerdt; Mared, Lena; Bjørtuft, Oystein; Ekmehag, Bjørn; Jansson, Kjell; Simonsen, Svein; Aukrust, Pål; Solbu, Dag; Iversen, Martin; Gullestad, Lars (2012). Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate. Journal of heart and lung transplantation, 31(3), pp. 259-65. New York, N.Y.: Elsevier 10.1016/j.healun.2011.12.010
Arora, Satish; Ueland, Thor; Wennerblom, Bertil; Sigurdardottir, Vilborg; Eiskjær, Hans; Bøtker, Hans E; Ekmehag, Bjorn; Jansson, Kjell; Mortensen, Svend-Aage; Saunamaki, Kari; Simonsen, Svein; Gude, Einar; Bendz, Bjørn; Solbu, Dag; Aukrust, Pål; Gullestad, Lars (2011). Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial. Transplantation, 92(2), pp. 235-243. Lippincott Williams & Wilkins 10.1097/TP.0b013e31822057f1
